ArticleJournal of imaging2025
Knee Cartilage Quantification: Performance of Low-Field MR in Detecting Low Grades of Chondropathy.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the diagnostic accuracy of T2 mapping on low-field (0.31 T) MRI for detecting low-grade knee chondropathy, using arthroscopy as the reference standard. Fifty-two patients (mean age 48.1 ± 17.2 years) undergoing arthroscopy for anterior cruciate ligament or meniscal tears were prospectively enrolled, excluding those with previous surgery, infection, or high-grade chondropathy (Outerbridge III-IV). MRI was performed with a 0.31 T scanner using a 3D SHARC sequence, and T2 relaxometric maps were generated for 14 cartilage regions per knee according to the WORMS classification. Arthroscopy, performed within one month by two blinded surgeons, served as the gold standard. A total of 728 regions were analyzed. T2 mapping differentiated healthy cartilage (grade 0) from early chondropathy (grades I-II) with an optimal cut-off of 45 ms and moderate discriminative accuracy (AUC = 0.714 for Reader 1 and 0.709 for Reader 2). Agreement with arthroscopy was good (κ = 0.731), with excellent intra-reader (ICC = 0.998) and good inter-reader reproducibility (ICC = 0.753). Most degenerative changes were located at the femoral condyles (59%). Low-field T2 mapping showed good diagnostic performance and reproducibility in detecting early cartilage degeneration, supporting its potential as a cost-effective and accessible quantitative biomarker for the assessment of cartilage integrity in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.